Introduction

Hepatitis B virus (HBV) infection produces a characteristic pattern of viral antigens, antibodies and nucleic-acid markers that change over the course of infection.

Correct interpretation of these markers allows us to determine:

• Whether HBV infection is present

• Whether infection is acute or chronic

• Whether infection has resolved

• Whether the patient is immune because of vaccination

• Whether viral replication is occurring

• Whether a patient is in the HBeAg-positive or HBeAg-negative state

• Whether a patient may be infectious

• Whether an apparently isolated anti-HBc result represents previous infection, occult infection, or a false-positive result

• Whether treatment is indicated when combined with clinical and biochemical parameters

The major HBV markers are:

Viral antigens

• HBsAg

• HBeAg

• HBcAg

Host antibodies

• Anti-HBs

• Anti-HBc IgM

• Anti-HBc total/IgG

• Anti-HBe

Molecular marker

• HBV DNA

Additional markers

• HBcrAg

• Quantitative HBsAg

• cccDNA — primarily a research/intrahepatic marker rather than a routine serum test

1. The HBV Serological Marker System

A useful conceptual sequence is:

HBV infection
      ↓
HBsAg appears
      ↓
HBeAg may appear
      ↓
HBV DNA detectable
      ↓
Anti-HBc IgM develops
      ↓
Anti-HBc IgG persists
      ↓
HBeAg disappears
      ↓
Anti-HBe appears
      ↓
HBsAg disappears
      ↓
Anti-HBs appears

However, these markers do not always appear in this exact sequence in every patient.

2. HBsAg

Hepatitis B surface antigen

HBsAg is the major serological marker of HBV infection.

It represents viral envelope/surface proteins produced from the S gene.

HBsAg is present on:

• Complete infectious virions

• Non-infectious spherical subviral particles

• Filamentous subviral particles

A large excess of HBsAg is produced compared with complete Dane particles.

3. Diagnostic Importance of HBsAg

HBsAg is the principal screening marker for HBV infection.

HBsAg positive

Generally indicates:

This may represent:

• Acute infection

• Chronic infection

• Occasionally transient positivity after vaccination

The duration is critical.

HBsAg persistence ≥6 months

Strongly establishes:

Chronic HBV infection

4. HBsAg in Acute Infection

HBsAg becomes detectable during the incubation period, usually before clinical symptoms.

It may become detectable before:

• jaundice

• ALT elevation

• anti-HBc IgM

Therefore:

During successful recovery:

HBsAg disappears

followed by:

anti-HBs appearance

5. HBsAg in Chronic Infection

If HBsAg persists for at least six months, the patient is considered to have chronic HBV infection.

Persistent HBsAg reflects:

• ongoing infection

• persistence of HBV-related templates

• continued production of viral surface proteins

Importantly:

A patient may have:

• HBsAg positive

• low HBV DNA

• normal ALT

• minimal liver inflammation

Therefore, HBsAg must be interpreted alongside HBV DNA, ALT, HBeAg and liver disease assessment.

6. Quantitative HBsAg

Quantitative HBsAg is expressed as:

IU/mL

Unlike qualitative HBsAg, which answers:

quantitative HBsAg asks:

qHBsAg may provide information about:

• viral activity

• immune control

• natural history

• treatment response

• likelihood of HBsAg loss

However:

Its interpretation varies with disease phase and treatment context.

7. HBeAg

Hepatitis B e antigen

HBeAg is a secreted viral protein derived from the precore/core region.

It is not a structural component of the mature virion.

Important distinction

HBcAg

→ core protein incorporated into nucleocapsids

HBeAg

→ secreted precore-derived antigen

8. What Does HBeAg Indicate?

HBeAg positivity generally indicates:

• active HBV replication

• high probability of detectable HBV DNA

• increased infectivity

However:

And:

This distinction becomes particularly important in HBeAg-negative chronic hepatitis.

9. HBeAg and Infectivity

Historically, HBeAg has been considered a marker of high infectivity.

In general:

HBeAg positive

→ high HBV replication

→ often high HBV DNA

→ increased infectiousness

But the best direct marker of replication is:

HBV DNA

Therefore, HBV DNA is preferred when accurately assessing viral replication.

10. HBeAg Seroconversion

The transition:

HBeAg positive

→

anti-HBe positive

is called:

HBeAg seroconversion

It generally reflects a transition toward reduced viral replication and immune control.

However, this does not necessarily mean:

• complete viral clearance

• absence of liver disease

• absence of HBV DNA

Some patients develop HBeAg-negative chronic hepatitis due to precore/basal core promoter variants.

11. Anti-HBe

Anti-HBe is antibody directed against HBeAg.

It generally appears after HBeAg disappears.

Typical sequence

HBeAg +
   ↓
HBeAg decline
   ↓
HBeAg disappearance
   ↓
Anti-HBe appearance

This is called:

HBeAg seroconversion

However, anti-HBe positivity must not automatically be interpreted as inactive infection.

12. HBcAg

Hepatitis B core antigen

HBcAg is the core protein of HBV.

It is located within the viral nucleocapsid.

HBcAg is highly immunogenic.

Critical laboratory point

HBcAg is not routinely detectable in serum using standard HBV serological testing.

Therefore, clinicians usually detect:

• anti-HBc IgM

• anti-HBc total/IgG

rather than serum HBcAg itself.

13. Anti-HBc

Anti-HBc means:

Antibody against hepatitis B core antigen

It indicates exposure to HBV.

Two major forms are clinically important:

• IgM anti-HBc

• IgG/total anti-HBc

14. IgM Anti-HBc

IgM anti-HBc is particularly important in:

Acute HBV infection

It usually appears around the onset of clinical disease.

Therefore:

HBsAg + IgM anti-HBc +

strongly supports:

Acute/recent HBV infection

15. IgM Anti-HBc Is Not Exclusively an Acute Marker

This is a very important advanced point.

IgM anti-HBc can also become detectable during:

• severe flares of chronic HBV infection

• HBeAg seroconversion

• acute exacerbations of chronic hepatitis B

Therefore:

Clinical context and previous serology are essential.

16. Total Anti-HBc

Total anti-HBc generally represents:

IgM + IgG anti-HBc

It is used widely in HBV screening.

A positive total anti-HBc indicates:

It does not result from vaccination alone.

This creates one of the most useful distinctions in HBV serology:

Vaccination

Anti-HBs positive

Anti-HBc negative

Natural infection

Anti-HBc positive

17. IgG Anti-HBc

IgG anti-HBc develops after HBV infection and generally persists long term.

It may remain detectable after:

• acute infection has resolved

• HBsAg has disappeared

• anti-HBs has developed

Therefore:

18. Anti-HBs

Antibody to hepatitis B surface antigen

Anti-HBs is the major protective antibody against HBV.

It develops after:

Natural recovery

or

Successful vaccination

Anti-HBs neutralizes HBV and prevents infection of susceptible hepatocytes.

19. Anti-HBs After Natural Infection

Following recovery:

HBsAg disappears

↓

anti-HBs appears

↓

anti-HBc remains positive

Typical pattern:

HBsAg −

Anti-HBc +

Anti-HBs +

This indicates:

Resolved natural HBV infection

20. Anti-HBs After Vaccination

After successful vaccination:

HBsAg −

Anti-HBc −

Anti-HBs +

This is the classic:

Vaccine-induced immunity

The key distinction is:

21. Protective Anti-HBs Level

A commonly used threshold for an adequate antibody response after vaccination is:

≥10 mIU/mL

This threshold is particularly relevant when evaluating post-vaccination seroprotection.

However, interpretation depends on:

• timing after vaccination

• vaccination history

• immune status

• clinical context

An anti-HBs level should therefore not be interpreted without knowing when vaccination occurred.

22. HBV DNA

HBV DNA is the most direct marker of:

Viral replication

It is measured using nucleic-acid amplification techniques, most commonly PCR-based methods.

HBV DNA can be detected before some serological markers become positive.

23. Why HBV DNA Is Important

HBV DNA is used for:

• confirming active viral replication

• baseline assessment before treatment

• monitoring antiviral therapy

• detecting virological breakthrough

• identifying resistance-associated patterns

• evaluating HBeAg-negative disease

• assessing occult infection in selected situations

24. HBV Viral Load

HBV DNA is generally reported in:

IU/mL

rather than simply copies/mL.

This allows greater standardization between assays.

A patient's HBV DNA should ideally be monitored using the same laboratory/assay platform when longitudinal comparison is important.

25. HBV DNA vs HBeAg

Therefore:

26. HBcrAg

Hepatitis B core-related antigen

HBcrAg is a composite marker reflecting several core/precore-related proteins, including:

• HBcAg

• HBeAg

• precore-related proteins

It can provide information related to:

• intrahepatic viral activity

• cccDNA transcriptional activity

• viral persistence

• risk of relapse in selected settings

HBcrAg is used more extensively in some research/specialist settings than in routine HBV diagnosis.

27. cccDNA

Covalently closed circular DNA

cccDNA is the persistent nuclear form of HBV DNA.

It is:

• located inside hepatocyte nuclei

• organized as a viral minichromosome

• transcriptionally active

• the template for viral RNA synthesis

Important

cccDNA is not routinely measured in serum.

Its measurement generally requires liver tissue and specialized molecular techniques.

Therefore:

28. HBV Marker Timeline

A simplified timeline can be visualized as:

Exposure
  ↓
HBV DNA
  ↓
HBsAg
  ↓
HBeAg
  ↓
IgM anti-HBc
  ↓
Total/IgG anti-HBc
  ↓
HBeAg disappearance
  ↓
Anti-HBe
  ↓
HBsAg disappearance
  ↓
Anti-HBs

The exact timing varies between individuals and depends on the stage of infection.

29. The HBV Window Period

One of the most important serological concepts is the:

Window period

During this interval:

HBsAg has disappeared

but

anti-HBs has not yet become detectable.

Therefore:

HBsAg −

anti-HBs −

The most useful marker is:

IgM anti-HBc +

This topic will be discussed in greater detail in the dedicated HBV window-period article.

30. Complete Marker Summary

31. The Three Most Important Serological Markers

For routine interpretation, remember:

1. HBsAg

Is HBV infection currently present?

2. Anti-HBc

Has the person ever been naturally infected with HBV?

3. Anti-HBs

Does the person have protective immunity?

This simple framework solves a large proportion of routine HBV serology questions.

32. Vaccination vs Natural Infection

This is one of the highest-yield comparisons.

Key rule

Anti-HBs + / anti-HBc − = vaccination-induced immunity

Anti-HBs + / anti-HBc + = previous natural infection

33. Acute HBV Infection

Typical pattern:

This pattern represents a typical acute infection, although exceptions occur.

34. Chronic HBV Infection

Typical chronic infection:

The major distinction from acute infection is:

Persistent HBsAg ≥6 months

35. Resolved HBV Infection

Typical pattern:

This indicates previous natural infection with immune control.

36. Isolated Anti-HBc

A particularly important pattern is:

HBsAg −

Anti-HBs −

Anti-HBc +

This is called:

Isolated anti-HBc positivity

Possible explanations include:

1. Remote resolved infection with waning anti-HBs

2. Window-period acute infection

3. Occult HBV infection

4. False-positive anti-HBc

5. Less commonly, other unusual serological patterns

Therefore:

Additional testing may be required depending on the clinical situation.

37. Occult HBV Infection

Occult HBV infection generally refers to:

HBV DNA detectable despite absence of detectable HBsAg.

A patient may have:

• HBsAg negative

• HBV DNA detectable

• anti-HBc positive or negative

• anti-HBs variable

Occult infection becomes particularly important in:

• immunosuppression

• chemotherapy

• transplantation

• certain blood/organ donation settings

• patients with unexplained liver disease

38. Serological Discordance

HBV serology may occasionally produce apparently contradictory patterns.

Examples:

• HBsAg positive + anti-HBs positive

• HBeAg negative + high HBV DNA

• Anti-HBc positive + HBsAg negative + anti-HBs negative

• HBsAg positive + undetectable HBV DNA

Possible explanations include:

• timing of infection

• serological transition

• viral mutations

• assay limitations

• occult infection

• low-level replication

• immune status

• laboratory error

Therefore:

39. HBsAg and Anti-HBs Coexistence

Although classically:

HBsAg + → anti-HBs −

and

HBsAg − → anti-HBs +

some patients may have simultaneous detection of both.

Possible explanations include:

• coexistence of different HBsAg/anti-HBs populations

• immune escape variants

• viral heterogeneity

• assay effects

• transitional states

This phenomenon is uncommon but clinically relevant.

40. Serological Marker Hierarchy

For practical interpretation:

HBsAg
   ↓
Current infection?
   ↓
Anti-HBc
   ↓
Natural exposure?
   ↓
IgM anti-HBc
   ↓
Recent infection?
   ↓
HBeAg / Anti-HBe
   ↓
Replication phase?
   ↓
HBV DNA
   ↓
Actual viral replication level
   ↓
Anti-HBs
   ↓
Protective immunity?

41. The “Five-Question” HBV Serology Method

Whenever a report arrives, ask:

Question 1

Is HBsAg positive?

→ Current infection is likely.

Question 2

Is anti-HBc positive?

→ Natural HBV exposure has occurred.

Question 3

Is IgM anti-HBc positive?

→ Recent infection or an acute flare should be considered.

Question 4

Is anti-HBs positive?

→ Protective immunity is present.

Question 5

What is the HBV DNA level?

→ Determines the degree of active viral replication.

Then integrate:

• HBeAg

• anti-HBe

• ALT

• fibrosis

• clinical history

42. High-Yield Serology Patterns

Remember that these are typical patterns, not absolute rules.

43. Serological Markers vs Molecular Markers

44. Why HBV Serology Is So Important

HBV serology allows us to distinguish:

Susceptible

from

Vaccinated

from

Acute infection

from

Window period

from

Chronic infection

from

Resolved infection

from

Occult infection

This is why HBV serology is one of the most important diagnostic frameworks in clinical microbiology and infectious diseases.

45. High-Yield Exam Pearls

Pearl 1

HBsAg = current infection.

Pearl 2

Anti-HBs = immunity.

Pearl 3

Anti-HBc = natural infection/exposure.

Pearl 4

Vaccination produces:

anti-HBs +

but:

anti-HBc −

Pearl 5

IgM anti-HBc is the key marker of recent/acute infection, but can also occur during flares of chronic HBV.

Pearl 6

The window period is classically characterized by:

HBsAg − + anti-HBs − + IgM anti-HBc +

Pearl 7

HBsAg persisting for ≥6 months indicates chronic infection.

Pearl 8

HBeAg generally correlates with active replication, but HBV DNA is the direct molecular marker of replication.

Pearl 9

HBeAg-negative disease can still have high HBV DNA.

Pearl 10

HBcAg itself is not routinely measured in serum.

Pearl 11

Anti-HBc does not arise from HBV vaccination.

Pearl 12

Isolated anti-HBc has multiple possible explanations and requires context.

46. One-Minute Revision

HBsAg
= CURRENT HBV INFECTION

Anti-HBs
= IMMUNITY

Anti-HBc
= NATURAL HBV EXPOSURE

IgM anti-HBc
= RECENT/ACUTE INFECTION
  (also possible in chronic flares)

HBeAg
= USUALLY ACTIVE REPLICATION/HIGH INFECTIVITY

Anti-HBe
= HBeAg SEROCONVERSION

HBV DNA
= DIRECT MARKER OF VIRAL REPLICATION

HBcrAg
= CORE-RELATED MARKER OF VIRAL ACTIVITY/PERSISTENCE

cccDNA
= INTRAHEPATIC PERSISTENT HBV RESERVOIR

47. The Golden HBV Serology Rule

When confronted with any HBV serology question, remember:

Once these five concepts are mastered, interpretation of virtually every HBV serological pattern becomes much easier.

Standard References

1. Knipe DM, Howley PM, editors. Fields Virology. Wolters Kluwer.

2. Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier.

3. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. Elsevier.

4. Carroll KC, et al. Jawetz, Melnick & Adelberg's Medical Microbiology. McGraw-Hill.

5. Ryan KJ, Ray CG. Sherris Medical Microbiology. McGraw-Hill.

6. World Health Organization. Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection. WHO, 2024.

7. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. Journal of Hepatology, 2025.

8. Terrault NA, et al. AASLD Guidance on Chronic Hepatitis B.

9. Centers for Disease Control and Prevention. Clinical Testing and Diagnosis for Hepatitis B.

10. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Reviews Immunology.

11. Ganem D, Prince AM. Hepatitis B virus infection—natural history and clinical consequences. New England Journal of Medicine.

12. Locarnini S, Hatzakis A, Chen DS, Lok A. Reviews and consensus literature on HBV virology, resistance and clinical management.